SCHEMBL1675140

SCHEMBL1675140

CCOC(=O)c1ccoc1-c1ccc2ncnc(N(C)Cc3sccc3C)c2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 9/20 0.70
CLK4 Q9HAZ1 18/20 0.60
CLK2 P49760 7/20 0.60
DYRK1A Q13627 7/20 0.60
DYRK1B Q9Y463 7/20 0.60
CDK2 P24941 1/20 0.60
CYP1A2 P05177 9/20 0.43
CYP3A4 P08684 9/20 0.43
CYP2D6 P10635 9/20 0.43
CYP2C19 P33261 9/20 0.43
TSHR P16473 8/20 0.43
LMNA P02545 8/20 0.43
USP2 O75604 7/20 0.43
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 5/20 0.43
MAPK1 P28482 5/20 0.43
CLK3 P49761 4/20 0.43
HIF1A Q16665 3/20 0.43
PIK3C2B O00750 1/20 0.40
PIK3C2G O75747 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675177 0.82 CLK1 (1.00) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675110 0.79 CLK4 (0.71) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675202 0.78 CLK1 (0.44) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675320 0.76 CLK1 (0.41) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675246 0.76 CLK4 (1.00) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675079 0.74 CLK1 (0.80) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675038 0.74 CLK4 (0.80) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675078 0.73 CLK4 (1.00) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675024 0.72 CLK4 (0.61) CLK1CLK4CLK2DYRK1ADYRK1B
SCHEMBL1675036 0.72 CLK4 (0.78) CLK1CLK4CLK2DYRK1ADYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed